Pages

Tuesday, July 29, 2025

 

FDA rethinking block on compounding of Lilly's obesity …

1 day ago · The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide.


No comments:

Post a Comment